// App-Quantinova.ai

: The SRPK1 inhibitor SPHINX31 prevents increased retinal permeability in a rodent model of diabetes

Researchers

Presenter

  • C. Allen

Principal Investigators

  • K. Horton

  • N. Malhi

  • J. Batson

  • D. Bates

Medical Centers

  • Cancer Biology‐ Division of Cancer and Stem Cells, University of Nottingham, Nottingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Streptozotocin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved